Editors' ChoiceCancer

An epigenetic tactic to treat RMS

See allHide authors and affiliations

Science Signaling  29 Aug 2017:
Vol. 10, Issue 494, eaap7466
DOI: 10.1126/scisignal.aap7466

Article Information

vol. 10 no. 494

DOI: 
https://doi.org/10.1126/scisignal.aap7466
Published By: 
Science Signaling
Print ISSN: 
1945-0877
Online ISSN: 
1937-9145
History: 
    Copyright & Usage: 
    Copyright © 2017, American Association for the Advancement of Science

    Author Information

    1. Leslie K. Ferrarelli
    1. Science Signaling, AAAS, Washington, DC 20005, USA

    Altmetric

    Article usage

    Article usage: August 2017 to June 2019

    AbstractFullPdf
    Aug 201712073320
    Sep 201714544010
    Oct 201744420
    Nov 201748200
    Dec 201732110
    Jan 201840140
    Feb 201843100
    Mar 201832130
    Apr 201825120
    May 201832150
    Jun 201814140
    Jul 20189120
    Aug 20180220
    Sep 20182140
    Oct 20180260
    Nov 20180180
    Dec 20180310
    Jan 20192280
    Feb 20192220
    Mar 20192190
    Apr 20190120
    May 20194200
    Jun 2019030

    View Full Text

    Article Tools

    • Email
    • Alerts

    • Citation tools

    • An epigenetic tactic to treat RMS

      By Leslie K. Ferrarelli

      Science Signaling

      BET inhibitors may be an effective treatment for some rhabdomyosarcomas.

      CiteULike logo Connotea logo del.icio.us logo Digg logo Facebook logo Google logo Mendeley logo Reddit logo Twitter logo

    Related Content

    Similar Articles in:

    Citing Articles in:

    Navigate This Article